急性前循環血栓切除術患者におけるストレス潰瘍治療薬の予防的使用と臨床転帰との関連
ストレス性潰瘍治療薬の予防的使用と急性前循環血栓切除術患者の臨床転帰との関連:前向き、多施設、観察コホート研究
Ischemic stroke accounts for a relatively high proportion of strokes. In recent years, intravenous thrombolysis and endovascular therapy have significantly improved the revascularization rate in patients with large vessel occlusive cerebral infarction, but 20-50% of patients still experience ineffective revascularization. Therefore, postoperative monitoring and treatment of patients with large vessel occlusions is crucial for early recognition, management and prevention of complications. Stress ulcer bleeding is a serious complication after acute ischemic stroke, with a prevalence of 1%-5%, and a previously proven incidence of stress ulcer bleeding after ischemic stroke. Stress ulcer bleeding after ischemic stroke has been shown to be closely associated with unfavorable outcomes, such as mortality. Current national and international guidelines or consensus on the prevention of stress ulcers after acute ischemic stroke do not advocate the routine use of histamine receptor antagonists or proton pump inhibitors for the prevention of stress ulcers, but rather should be considered in the context of the patient's risk factors for stress ulcers and discontinued after the patient initiates enteral nutrition. However, there is no evidence-based medical evidence to support the risk-benefit relationship of stress ulcer drug prophylaxis in patients with mechanical thrombectomy for acute anterior circulation large vessel occlusion.
調査の概要
状態
状態
条件
条件
詳細な説明
Stress ulcer bleeding is a serious complication after acute ischemic stroke, with a prevalence of 1%-5%, of which only 0.5%-1% require blood transfusion or result in hypotension. Stress ulcer bleeding after ischemic stroke has been shown to be associated with poor outcomes, such as mortality, and basilar artery occlusion and middle cerebral artery cerebral infarction are independent risk factors for stress ulcer bleeding after acute ischemic stroke. Guidelines or consensus on the prevention of stress ulcers after acute ischemic stroke do not advocate the routine use of histamine receptor antagonists or proton pump inhibitors for stress ulcer prevention.
However, stress ulcer prophylaxis is initiated in most patients admitted to the neurological intensive care unit after mechanical embolization of acute anterior circulation large vessel occlusion. With advances such as diagnosis and early initiation of enteral nutrition, the rate of stress ulcer bleeding in patients with mechanical embolization of acute anterior circulation large vessel occlusion is significantly reduced. The relationship between the risk and benefit of SUP in patients undergoing mechanical embolization for acute anterior circulation large vessel occlusion is not yet supported by evidence-based medical evidence. Therefore, the purpose of this study was to investigate the correlation between pharmacological stress ulcer prophylaxis and clinical outcomes in patients undergoing mechanical thrombectomy for acute anterior circulation large vessel occlusion.
研究の種類
研究の種類
入学 (推定)
入学
連絡先と場所
研究連絡先
研究連絡先
- 名前:Suyue Pan, M.D., Ph.D.
- 電話番号:13556184981
- メール:pansuyue@smu.edu.cn
研究場所
-
-
Fujian
-
Fuzhou、Fujian、中国
- 募集
- Fujian Medical University Union Hospital
-
コンタクト:
- Shenggen Chen, M.D.
- 電話番号:13459480275
-
-
Guangdong
-
Dongguan、Guangdong、中国
- 募集
- Dongguan People's Hospital
-
コンタクト:
- Zhu Shi, M.D.
- 電話番号:13669825459
-
Dongguan、Guangdong、中国
- 募集
- Dongguan donghua hospital
-
コンタクト:
- Lingyu Sun
- 電話番号:13829203368
-
Guangzhou、Guangdong、中国
- 募集
- Nanfang Hospital of Southern Medical University
-
コンタクト:
- Suyue Pan
- 電話番号:13556184981
-
Guangzhou、Guangdong、中国
- 募集
- Guangdong Provincial Hospital of Traditional Chinese Medicine
-
コンタクト:
- Lixin Wang, M.D.
- 電話番号:13922793886
-
Guangzhou、Guangdong、中国
- 募集
- Huadu District People's Hospital of Guangzhou
-
コンタクト:
- Guangning Li, M.D.
- 電話番号:13926239656
-
Guangzhou、Guangdong、中国
- 募集
- The Fourth Affiliated Hospital of Guangzhou Medical University
-
コンタクト:
- Wangchi Luo, M.D.
- 電話番号:13710895142
-
Heyuan、Guangdong、中国
- 募集
- Heyuan people's Hospital
-
コンタクト:
- Minzhen Zhu
- 電話番号:15007622318
-
Huizhou、Guangdong、中国
- 募集
- Huizhou Municipal Central Hospital
-
コンタクト:
- Lizhi Wang, M.D.
- 電話番号:13802872076
-
-
Hainan
-
Haikou、Hainan、中国
- 募集
- Hainan Provincial People's Hospital
-
コンタクト:
- Fan Zhang, M.D.
- 電話番号:17389897580
-
Haikou、Hainan、中国
- 募集
- Haikou People's Hospital
-
コンタクト:
- Guoshuai Yang, M.D.
- 電話番号:13876006248
-
Haikou、Hainan、中国
- 募集
- Hainan Traditional Chinese Medicine Hospital
-
コンタクト:
- Yong Gu, M.D.
- 電話番号:15521280288
-
-
Hunan
-
Changsha、Hunan、中国
- 募集
- The First Hospital of Changsha
-
コンタクト:
- Xu Peng, M.D。
- 電話番号:15802507292
-
Hengyang、Hunan、中国
- 募集
- The Second Hospital University of South China
-
コンタクト:
- Yanhong Hu, M.D.
- 電話番号:13265004191
-
Yueyang、Hunan、中国
- 募集
- Yueyang People's Hospital
-
コンタクト:
- Yuan Zhou, M.D.
- 電話番号:15107309796
-
-
Inner Mongolia
-
Baotou、Inner Mongolia、中国
- 募集
- Sinopharm North Hospital
-
コンタクト:
- Lifei Xing, M.D
- 電話番号:15354919958
-
Hohhot、Inner Mongolia、中国
- 募集
- The Affiliated Hospital of Inner Mongolia Medical University
-
コンタクト:
- Lihua Sun, M.D.
- 電話番号:18686292585
-
-
Jiangxi
-
Ganzhou、Jiangxi、中国
- 募集
- Ganzhou City People's Hospital
-
コンタクト:
- Zhaohui Lai
- 電話番号:13879729792
-
-
Zhejiang
-
Wenzhou、Zhejiang、中国
- 募集
- Second Affiliated Hospital of Wenzhou Medical University
-
コンタクト:
- Saijun Zhou, M.D.
- 電話番号:13857746659
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Patients who are treated with mechanical thrombectomy with acute anterior circulation large vessel occlusion. ≥18 years of age, within 24 hours of onset. Expected survival >3 months. NIHSS score ≥ 6 at onset of illness.
説明
Inclusion Criteria:
- Age ≥18 years.
- Within 24 hours of onset. Meet the criteria for diagnosis of acute ischemic stroke in the "China Acute Ischemic Stroke Diagnosis and Treatment Guidelines 2018".
- Meet the indications for mechanical thrombectomy in the "Chinese Guidelines for Early Endovascular Interventions in Acute Ischemic Stroke 2022".
- Treated with mechanical thrombectomy.
- NIHSS score ≥ 6 at onset of illness.
- Sign an informed notice.
Exclusion Criteria:
Allergy to drug ingredients. Women who are pregnant or breastfeeding. Life expectancy of less than 3 months due to other non-ischemic stroke diseases such as malignancy, severe liver or renal failure.
Have participated in other interventional clinical studies (affecting the outcome of this cohort study).
Participants who were judged by the investigator to be unsuitable for participation in this study.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
グループ/コホートの数
コホートと介入
グループ/コホートグループ/コホート |
|---|
|
Stress Ulcer Prophylaxis
Subjects are on stress ulcer medications including PPIs, H2RBs, and mucosal protectors at 24 h of admission. |
|
Control Group
Subjects are not on stress ulcer medications including PPIs, H2RBs, and mucosal protectors at 24 h of admission. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
90-day mortality after onset
時間枠:90-day after onset
|
Proportion of enrolled patients who died 90 days after onset of disease. |
90-day after onset
|
|
Incidence of stroke-associated pneumonia
時間枠:within 7-day of onset
|
Incidence of non-mechanically ventilated stroke patients with new pneumonia within 7-day of onset |
within 7-day of onset
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of clinically significant bleeding
時間枠:within 7-day of onset
|
One of the following 4 symptoms occurs within 24 hours of bleeding from a stress ulcer (in the absence of other causes):1. A decrease of ≥ 20 mmHg in any one of systolic, diastolic and mean arterial pressure. 2.Initiation of blood pressure boosters or 20% increase in medication dose.3. Decreased hemoglobin ≥ 2 g/d((1.24 mmol/l). 4.Infusion of erythrocytes ≥ 2 U. |
within 7-day of onset
|
|
Incidence of stress ulcer bleeding
時間枠:7-day after onset
|
Coffee-like residue/black stool/blood in stool within 7-day after onset and more than 2 consecutive positive fecal/gastric fluid occult blood |
7-day after onset
|
|
Incidence of unfavorable functional prognosis at 90 days after onset
時間枠:90-day after onset
|
Incidence of unfavorable functional prognosis at 90 days after onset |
90-day after onset
|
|
90-day mRS score change
時間枠:90-day after onset
|
Modified Rankin Scale score change within 90 days after onset in patients who were eligible for inclusion criteria |
90-day after onset
|
|
Incidence of early neurological deterioration
時間枠:within 72 hours after onset
|
Increased score of National Institutes of Health Stroke Scale within 72h after onset ≥ 4 |
within 72 hours after onset
|
|
1-year post-onset mortality
時間枠:1 year after onset
|
Mortality at 1 year after onset in patients who were eligible for inclusion criteria |
1 year after onset
|
|
Incidence of adverse related events such as pneumonia or myocardial ischemia 1 year after onset
時間枠:1 year after onset
|
Incidence of adverse related events such as pneumonia or myocardial ischemia 1 year after onset in patients who were eligible for inclusion criteria |
1 year after onset
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者:Suyue Pan、Department of Neurology, Nanfang Hospital,Southern Medical University
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- NFEC-2023-040
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。